ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Chongqing Peg-Bio Biopharm Co., Ltd. clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 11 studies whose lead sponsor is Chongqing Peg-Bio Biopharm Co., Ltd. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 22, 2026.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

Compare Chongqing Peg-Bio Biopharm with Changchun GeneScience Pharmaceutical and Takeda →

Pipeline: 5 programs

Each counted once: 5 with a study Chongqing Peg-Bio Biopharm Co., Ltd. leads registered in the last two years.

  • Phase 1
  • Phase 2

The 5 programs — sign in to see the list, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Chongqing Peg-Bio Biopharm Co., Ltd.’s own registered studies; Chongqing Peg-Bio Biopharm Co., Ltd.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Chongqing Peg-Bio Biopharm Co., Ltd.’s studies test, most studies first; none is open now — 2 drugs with a page of their own. Each count opens the studies in search.

Studies, none open

Coming up

3 of Chongqing Peg-Bio Biopharm Co., Ltd.’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. 1F
  5. M
  6. 1A
  7. M
  8. 1J
  9. J
  10. A
  11. S
  12. O
  13. N

Add all 3 to your calendar (.ics) → With an account.

All 11 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now327%
  • Under way, not recruiting19%
  • Completed764%

Phase

  • Phase 19
  • Phase 22
  • Phase 31

Where

Over the years

  1. 22
  2. 23
  3. 24
  4. 425
  5. 126

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Chongqing Peg-Bio Biopharm Co., Ltd.

  • Chongqing Peg-Bio Biopharm Co., Ltd.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    11 studies

Studies

Recruiting first, then most recently updated. Showing 11 of 11.